Cerulean Announces Results from Phase 2b Cancer Trial

CRLX101 is being studied in clinical trials in renal cell carcinoma in combination with Avastin®03/23/2013
Source: Kidney Cancer Association - Category: Cancer & Oncology Source Type: news